REGISTERED
on 14 Dec 2021
Last Applicant/ Owned by
4455 GENESEE STREET
BUFFALO
NY
14225
Serial Number
90188918 filed on 17th Sep 2020
Registration Number
6591723 registered on 14th Dec 2021
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
PLX PHARMA INC.
Aspirin; Pain relief medication; Fever relief medication; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of arthritis, rheumatoid arthritis, and osteoarthritis; Cardiovascular pharmaceuticals; Pharmaceutical treatments for the prevention and treatment of vascular disease; Pharmaceutical products for the prevention and treatment of cancer; Phar Read More
Classification Information
Class [005]
Pharmaceutical Products
Aspirin; Pain relief medication; Fever relief medication; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of arthritis, rheumatoid arthritis, and osteoarthritis; Cardiovascular pharmaceuticals; Pharmaceutical treatments for the prevention and treatment of vascular disease; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for treating hypertension; Pharmaceutical products for treating diabetes; Pharmaceuticals in the field of human medicine
First Use Date in General
14th Aug 2021
First Use Date in Commerce
14th Aug 2021
Mark Details
Serial Number
No 90188918
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 11577.001 en
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.02 -
Wavy line(s), band(s) or bar(s)
26.17.06 -
Diagonal line(s), band(s) or bar(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Sep 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 14th Dec 2021 | REGISTERED-PRINCIPAL REGISTER |
| 06th Nov 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 05th Nov 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 22nd Oct 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 22nd Oct 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| 07th Oct 2021 | TEAS STATEMENT OF USE RECEIVED |
| 07th Oct 2021 | USE AMENDMENT FILED |
| 13th Apr 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 16th Feb 2021 | PUBLISHED FOR OPPOSITION |